Part I – Pharmas and social networking
I was talking to some folks at a big global pharma last week and I discovered that pharma doesn’t like social networking. (Give me a break – I’m a software security guy, I think about these things in terms of threats to intellectual property and I thought everyone “gets” social networking). If you understand how […]
Off-label marketing
I recently read an article by Adriane Fugh-Berman and Douglas Melnick about Off-Label Promotion, On-Target Sales In the pharmaceutical industry, there are two ways to market an approved drug for a new use: the “indication” route—performing studies necessary for regulatory approval—or the “publication” strategy, which stimulates off-label prescribing by using research “to disseminate the information […]
